Type II respiratory immunophlogosis: review of our case series in the light of the Clinical-Cytological-Grading (CGC)

F.Asprea, G.Lucchesi, D. Costanzo, G.Micali

Abstract: In a recent scientific publication Gelardi and al. described the Clinical-Cytological-Grading as an additional score to be used in association with SNOT-22 et al NPS in the evaluation of patients with chronic sinusitis and nasal polyposis in order to identify those who are correctly eligible for  biological therapy in clinical practice. In this paper, the authors review their series of patients with nasal polyposis treated with monoclonal antibodies in order to assess whether the prescription of the therapy was appropriate in the light of the GCC.

Keywords: Chronic Rhinosinositis, nasal polyps, monoclonal antibodies, mepolizumab, dupilumab, Clinical-Cytological-Grading.

Title: Type II respiratory immunophlogosis: review of our case series in the light of the Clinical-Cytological-Grading (CGC)

Author: F.Asprea, G.Lucchesi, D. Costanzo, G.Micali

International Journal of Healthcare Sciences

ISSN 2348-5728 (Online)

Vol. 10, Issue 2, October 2022 - March 2023

Page No: 187-190

Research Publish Journals

Website: www.researchpublish.com

Published Date: 17-January-2023

DOI: https://doi.org/10.5281/zenodo.7544112

Vol. 10, Issue 2, October 2022 - March 2023

Citation
Share : Facebook Twitter Linked In

Citation
Type II respiratory immunophlogosis: review of our case series in the light of the Clinical-Cytological-Grading (CGC) by F.Asprea, G.Lucchesi, D. Costanzo, G.Micali